NCT04791709

Brief Summary

The purpose of this study is to look at the best ways to prevent cognitive decline (loss of memory and/or functioning) in midlife and older Latino adults living with HIV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 10, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2025

Completed
7 months until next milestone

Results Posted

Study results publicly available

October 20, 2025

Completed
Last Updated

October 20, 2025

Status Verified

October 1, 2025

Enrollment Period

3.1 years

First QC Date

March 5, 2021

Results QC Date

August 20, 2025

Last Update Submit

October 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants Completing the Study

    Feasibility of HOLA will be reported as the percentage of participants completing the post intervention assessment.

    16 weeks

Secondary Outcomes (9)

  • Changes in Neurocognitive Impairment as Measured by the Trails Making Test

    Baseline, 16 weeks

  • Changes in Neurocognitive Impairment as Measured by the WAIS-IV Digit Span

    Baseline, 16 weeks

  • Changes in Physical Activity as Measured by the Global Physical Activity Questionnaire (GPAQ)

    Baseline, 16 weeks

  • Changes in Depression as Measured by the PHQ-9

    Baseline, 16 weeks

  • Changes in Anxiety as Measured by the GAD-7

    Baseline, 16 weeks

  • +4 more secondary outcomes

Study Arms (1)

HOLA Group

EXPERIMENTAL

Participants in this group will receive a multicomponent intervention for 16 weeks.

Behavioral: Happy Older Latinos are Active (HOLA)

Interventions

HOLA is a multicomponent health promotion intervention. First component is a one-on-one social and physical activation with the participant and the community health worker (CHW). Each session will last approximately 30 minutes at day 1 and week 8. The second component is a group walk led by a CHW for 45 minutes, 3 times a week, for 16 weeks. The third component consists of scheduling pleasant events at the end of each group walk session.

HOLA Group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • are Latino (self-identified);
  • are age 50+;
  • are HIV infected but are virologically suppressed (viral load \<200 copies/mL);
  • volunteer informed consent

You may not qualify if:

  • have diagnosis of any neurodegenerative disorder or dementia (Parkinson's disease, Alzheimer's disease, vascular, frontotemporal dementia, etc.) or significant cognitive impairment as indicated by a Telephone Interview for Cognitive Status (TICS) score less than or equal to 30;
  • have other conditions that could impact cognitive functioning or testing (e.g., legally blind or deaf), currently undergoing radiation or chemotherapy, a history of brain trauma with a loss of consciousness greater than 30 minutes.
  • have contraindications to physical activity outlined in the American College of Sports Medicine standards or severe medical illness that precludes them from safely participating in a health promotion intervention.
  • are unable to complete 10-meter walk test.
  • have plans to move outside of the Miami metropolitan area within the next 6 months or are not living in stable housing (e.g. group home).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

Location

Related Publications (1)

  • Jimenez DE, Ross EJ, Weinstein E, Gouse H, Pan Y, Martinez Garza D, Burke SL, Joo JH, Behar-Zusman V. Preventing Cognitive Decline in Older Latino Adults With HIV Through a Culturally Tailored Health Promotion Intervention: Protocol for a Single-Arm Pilot Trial. JMIR Res Protoc. 2024 Aug 12;13:e55507. doi: 10.2196/55507.

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Results Point of Contact

Title
Dr. Daniel Jimenez
Organization
University of Miami

Study Officials

  • Daniel Jimenez, Ph.D.

    University of Miami

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 5, 2021

First Posted

March 10, 2021

Study Start

February 1, 2022

Primary Completion

March 12, 2025

Study Completion

March 12, 2025

Last Updated

October 20, 2025

Results First Posted

October 20, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations